24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

24/7 (NASDAQ: NLSP) NLS PHARMACEUTICS. shares are up this morning at .73 an increase of more than 22% in pre-market trading. More than 1,600 trades have gone off and 733k plus in volume.

The company announced a positive opinion this morning.

NLS Pharmaceutics Announces Positive Opinion from European Regulators to Grant Orphan Drug Designation for Mazindol ER in Idiopathic Hypersomnia

RelatedNews

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

Want more news like this? Check out our homepage!

Recent News

Xcel Brands and G-III Apparel Group Agree to New 25-Year Master Licensing Partnership

Hoth Therapeutics Reports Positive Preclinical Alzheimer’s Treatment Results

Brera Holdings Obtains Tactical Stake in Manchester United

FDA Grants Timber Pharmaceuticals CARC Waiver for TMB-001

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Search by keyword

Add New Playlist